Bretylium tosylate as an antiarrhythmic agent
Borkowski, P.J.
Kardiologia Polska 13(2): 195-198
1970
ISSN/ISBN: 0022-9032 PMID: 5433233 Document Number: 20128
Document emailed within 1 workday
Related Documents
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284Steffen, V.; Assmann, I.; Fiehring, H. 1976: Clinical experiences with bretylium tosylate Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(17): 684-688
Szulc, E.J. 1971: Value of bretylium tosylate in controlling arrhythmia Wiadomosci Lekarskie 24(18): 1783-1785
Lee, Y.C.; Malick, A.W.; Amann, A.H.; Baaske, D.M.; Shah, J.J.; Wagenknecht, D.M.; Carter, J.E. 1981: Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin American Journal of Hospital Pharmacy 38(2): 183-187
Dhurandhar, R.W.; Pickron, J.; Goldman, A.M. 1980: Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction Heart and Lung: the Journal of Critical Care 9(2): 265-270
Parker, T.S.; Macri, J.R.; Jenden, D.J. 1976: A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine) Proceedings of the Western Pharmacology Society 19: 79-86
Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R. 1985: Propafenone--a new antiarrhythmic agent. Clinical experience Casopis Lekaru Ceskych 124(13): 407-410
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Gülker, H.; Thale, J.; Olbing, B.; Heuer, H.; Frenking, B.; Bender, F. 1985: Assessment of the antiarrhythmic profile of the new class i agent diprafenone Arzneimittel-Forschung 35(9): 1387-1393
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697
Karapetian, A.E.; Gevorkian, R.A. 1972: Action of 4-methyluracil as an antiarrhythmic agent stimulating the growth of myocardial cells Farmakologiia i Toksikologiia 35(3): 297-299
Cheng, Y.N.; Kiyosue, T.; Arita, M. 1994: Effects of KT-362, a new antiarrhythmic agent, on membrane ionic currents of guinea pig ventricular myocytes Journal of Pharmacology and Experimental Therapeutics 270(3): 851-857
Valkó, I.; Szepesi, G. 1990: An improved TLC method for investigation of the metabolic profile of BGYKI-38233--a new antiarrhythmic agent Die Pharmazie 45(4): 290
Beck, O.A.; Witt, E.; Hochrein, H. 1975: Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography Zeitschrift für Kardiologie 64(2): 179-187
Fiset, C.; Drolet, B.; Hamelin, B.A.; Turgeon, J. 1997: Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class IIi antiarrhythmic drug dl-sotalol Journal of Pharmacology and Experimental Therapeutics 283(1): 148-156
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Chen, C.L.; Sangiah, S.; Patterson, E.; Berlin, K.D.; Garrison, G.L.; Dunn, W.; Nan, Y.; Scherlag, B.J.; Lazzara, R. 1992: Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force Research Communications in Chemical Pathology and Pharmacology 78(1): 3-16
Murakami, M.; Kinukawa, M.; Kanazawa, T.; Maruyama, K.; Miyagi, M.; Miyata, H.; Ujiie, A. 1996: Effects of the new class i antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity Journal of Pharmacology and Experimental Therapeutics 279(2): 877-883
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355